The Australian pharmaceutical industry is making a major contribution to returning the Federal Budget to surplus, trade group Medicines Australia chief executive Brendan Shaw reminded Treasurer and Deputy Prime Minister Wayne Swan yesterday.
In Medicines Australia's pre-Budget submission to the Treasurer, Dr Shaw underscored the importance of Medicines Australia's Memorandum of Understanding with the Commonwealth which was delivering A$1.9 billion ($2.02 billion) in savings to the Pharmaceutical Benefits Scheme.
Estimates commissioned by the government show that the original 2007 reforms to the PBS will generate up to A$5.8 billion in savings by 2018, Dr Shaw told the Treasurer in a letter. The PBS grew by just 2.4% in nominal terms in 2011, less than the inflation rate of 3.1%, suggesting that government spending on the PBS fell in real terms in 2011.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze